The release of the substrate for xanthine oxidase in hypertensive patients was suppressed by angiotensin converting enzyme inhibitors and α1-blockers

Journal of Hypertension

Volumn 19, Issue 3 SUPPL., 2001, Pages 575-582

  Ohtahara, A ^a   Hisatome, I ^a   Yamamoto, Y ^a   Furuse, M ^a   Sonoyama, K ^a   Furuse, Y ^a   Hamada, T ^a   Katoh, M ^a   Watanabe, M ^a   Kinugawa, T ^a   Ogino, K ^a   Igawa, O ^a   Shimomuram, T ^a   Murakami, F ^a   Yamamoto, T ^a   Shigemasa, C ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

ACE inhibitor; Hypertension; Hypoxanthine; Hypoxia; Skeletal muscle; Uric acid; 1 blocker

Indexed keywords

ADENOSINE PHOSPHATE DEAMINASE; ALACEPRIL; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; AMMONIUM DERIVATIVE; ATENOLOL; BEVANTOLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; HYPOXANTHINE DERIVATIVE; LACTIC ACID; LOSARTAN; MANIDIPINE; OXYGEN RADICAL; URIC ACID; XANTHINE OXIDASE;

ADULT; AGED; BLOOD VESSEL INJURY; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; EXERCISE; FEMALE; HUMAN; HYPERTENSION; HYPERURICEMIA; HYPOXIA; MAJOR CLINICAL STUDY; MALE; OXIDATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SKELETAL MUSCLE; URIC ACID BLOOD LEVEL; VASCULAR RESISTANCE;

EID: 17744377600     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200103001-00009     Document Type: Conference Paper

References (49)

1. Does treatment-mediated increase in uric acid reduce the cardioprotective effect of diuretics in hypertensive patients?
2. Relation of serum uric acid to modality and ischemic heart disease. The NHANES 1 epidemiologic follow-up study
3. Uric acid as an independent risk factor in the treatment of hypertension
4. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus
5. Spatial and temporal correlation between leukocyte behavior and cell injury in post-ischemic rat skeletal muscle microcirculation
6. Temporal correlation between maximum tetanic force and cell death in postischemic rat skeletal muscle
7. Localization of xanthine oxidase in mammary-gland epithelium and capillary endothelium
8. Significance of xanthine oxidase in capillary endothelial cells
9. Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial cell surface
10. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hydroethidine microfluorography
11. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats
12. Adenosine deaminase inhibitor prevents free radicals-induced injury in the post-ischemic head
13. Accelerated purine nucleotide degradation by anaerobic but not by aerobic ergometer muscle exercise
14. Myoadenylate deaminase deficiency
15. Excess release of hypoxanthine from exercising muscles in two gout patients with HGPRTase deficiency: Lack of ammonium release
16. Towards the physiological function of uric acid
17. Observations on the blood ciculation in voluntary muscle in man
18. Theory of the use of aderiovenous concentration differences for measuring metabolism in steady and non-steady states
19. Purine metabolism during strenuous muscular exercise in man
20. Blood pressure response in relation to blood lactate during exercise in patients with essential hypertension
21. Skeletal muscle characteristics: Relationships to cardiovascular risk factors
22. Quantitative ultrastructure of mammalian skeletal muscle
23. Effects of angiotensin receptor antagonist and angiotensin converting enzyme inhibitor on insulin sensitivity in fructose-fed hypertensive rats and essential hypertensives
24. Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension
25. Divergent effects of ACE-inhibition and calcium channel blockade on NO-activity in systemic and renal circulation in essential hypertension
26. Inhibitory effect of insulin on bradykinin-induced venodilation
27. Lacipidine restores endothelium-dependent vasodilation in essential hypertensive patients
28. Vascular reactivity to phenylephrine and angiotensin II: Comparison of direct venous and systemic vascular responses
29. Evidence of increased sympathetic vasomotor drive with shorter acting dihydropyridine calcium channel antagonists in human hypertension: A study using spectral analysis of RR interval and systolic arterial pressure variability
30. Propranolol enhances adenine nucleotide degradation in human muscle during exercise
31. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure
32. Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure
33. Tourniquet-induced exsanguination in patients requiring lower limb surgery
34. Overnight urinary acid: Creatinine ratio for the detection of sleep hypoxemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure
35. Nocturnal increase of urinary uric acid: Creatinine ratio. A biochemical correlate of sleep-associated hypoxia
36. Measurement of uric acid as a marker of oxygen tension in the lung
37. Hypoxanthine levels in amniotic fluid: An indicator for fetal hypoxia?
38. Hyperuricemia in cyanotic congenital heart disease
39. Effects of diltiazem on plasma uric acid level and renal uric acid excretion in rats
40. Serum uric acid ACE, inhibitors, and natriuresis
41. Captoril once daily as monotherapy in patients with hyperuricemia and essential hypertension
42. Pilot study of the uricosuric effect of DuP-753, a new angiotensin II receptor antagonist, in healthy subjects
43. Effects of eposartan and Iosartan on uric acid metabolism in patients with essential hypertension
44. Plasma hydrogen peroxide production in hypertensive and normotensive subjects at genetic risk of hypertension
45. Does superoxide underlie the pathogenesis of hypertension?
46. Cellular and molecular mechanisms of endothelial cell dysfunction
47. Xanthine oxidase inhibition with oxypurinolol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients
48. Working group on management of patients with hypertension and high blood cholesterol. National education programs working group report on the management of patients with hypertension and high blood cholesterol
49. Serum uric acid and cardiovascular events in successfully treated hypertensive patients